Rote William E. Insider Trades

Insider Trading History

Track insider trading activity for Rote William E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $5.22M 115,474 shares
Last Trade
May 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$121k 2,763 shares
$43.95
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $384k 8,500 shares
Last Trade
May 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 8,500 shares
$44.91
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $192k 4,250 shares
Last Trade
May 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$191k 4,250 shares
$44.91
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $5.34M 118,237 shares
Last Trade
May 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$191k 4,250 shares
$44.91
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $5.15M 113,987 shares
Last Trade
Apr 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$356k 9,100 shares
$39.09
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $5.56M 123,087 shares
Last Trade
Apr 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 14,000 shares
$30.70
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $4.93M 109,087 shares
Last Trade
Feb 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$409k 12,446 shares
$32.87
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $2.42M 53,570 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.77M 53,570 shares
$33.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $5.49M 121,533 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$625k 20,090 shares
$31.09
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $0 0 shares
Last Trade
Dec 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.42M 60,000 shares
$40.28
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $7.3M 161,443 shares
Last Trade
Dec 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.42M 60,000 shares
$40.28
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $4.59M 101,443 shares
Last Trade
Dec 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.41M 60,000 shares
$40.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $4.53M 100,241 shares
Last Trade
May 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.3k 3,198 shares
$21.05
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $4.68M 103,439 shares
Last Trade
May 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 4,920 shares
$21.15
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $222k 4,920 shares
Last Trade
May 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 4,920 shares
$21.15
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
SENIOR VICE President, R&d
Holding Value $4.45M 98,519 shares
Last Trade
Feb 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$122k 5,200 shares
$23.53
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
SENIOR VICE President, R&d
Holding Value $0 0 shares
Last Trade
Feb 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$169k 8,000 shares
$21.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
SENIOR VICE President, R&d
Holding Value $4.69M 103,719 shares
Last Trade
Feb 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$169k 8,000 shares
$21.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
SENIOR VICE President, R&d
Holding Value $4.33M 95,719 shares
Last Trade
Feb 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$177k 8,951 shares
$19.78
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
SENIOR VICE President, R&d
Holding Value $4.73M 104,670 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 58,000 shares
$20.46
$45.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up